Microbiome and probiotics: Link to arthritis

Current Opinion in Rheumatology

Volumn 26, Issue 4, 2014, Pages 410-415

  Bedaiwi, Mohamed K ^a   Inman, Robert D ^a  

^a TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

ankylosing spondylitis; inflammatory bowel disease; microbiome; probiotics; rheumatoid arthritis

Indexed keywords

HLA B27 ANTIGEN; PROBIOTIC AGENT;

ANKYLOSING SPONDYLITIS; ARTHRITIS; BACTEROIDES; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM LONGUM; COLITIS; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; KLEBSIELLA PNEUMONIAE; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LACTOBACILLUS RHAMNOSUS; LACTOBACILLUS SALIVARIUS; MICROBIOME; MOUTH HYGIENE; NONHUMAN; PORPHYROMONAS GINGIVALIS; PREVOTELLA; PREVOTELLA COPRI; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SPONDYLARTHRITIS; STREPTOCOCCUS ANGINOSUS; TANNERELLA FORSYTHENSIS;

EID: 84901844090     PISSN: 10408711     EISSN: 15316963     Source Type: Journal    
DOI: 10.1097/BOR.0000000000000075     Document Type: Review

References (47)

1. Yeoh N, Burton JP, Suppiah P, et al. The role of the microbiome in rheumatic diseases. Curr Rheumatol Rep 2013; 15:903-907.
2. Simon GL, Gorbach SL. Intestinal flora in health and disease. Gastroenter-ology 1984; 86:174-193. (Pubitemid 14177335)
3. Maslowski KM, Mackay CR. Diet gut microbiota and immune responses. Nat Immunol 2011; 12:5-9.
4. Sanz FY, Santacruz A, Gauffin P. Gut microbiota in obesity and metabolic disorders. Proc Nutr Soc 2010; 69:434-441.
5. Klareskog L, Catrina AI, Paget S. Rheumatoid arthritis. Lancet 2009; 373:659-672.
6. McMichael AJ, Sasazuki T, McDevitt HO, et al. Increased frequency of HLA-Cw3 and HLA-Dw4 in rheumatoid arthritis. Arthritis Rheum 1977; 20:1037.
7. Stastny P. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med 1978; 298:869.
8. Aho K, Koskenvuo M, Tuominen J, et al. Occurrence of rheumatoid arthritis in a nationwide series of twins. J Rheumatol 1986; 13:899-902. (Pubitemid 17203922)
9. Silman AJ, MacGregor AJ, Thomson W, et al. Twin concordance rates for rheumatoid arthritis: results from a nationwide study. Br J Rheumatol 1993; 32:903-907. (Pubitemid 23301303)
10. Jayatilake JAMS, Rajapakse S, Weerasinghe IE, et al. Oral hygiene and periodontal status in a group of patients with rheumatoid arthritis. Indian J Rheumatol 2011; 6:111-115.
11. Ortiz P, Bissada N, Palomo L, et al. Periodontal therapy reduces the severity of active rheumatoid arthritis in patients treated with or without tumor necrosis factor inhibitors. J Periodontol 2009; 80:535-540.
12. Martinez-Martinez RE, Abud-Mendoza C, Patiño-Marin N, et al. Detection of periodontal bacterial DNA in serum and synovial fluid in refractory rheumatoid arthritis patients. J Clin Periodontol 2009; 36:1004-1010.
13. Moen K, Brun J, Valen M, et al. Synovial inflammation in active rheumatoid arthritis and psoriatic arthritis facilitates trapping of a variety of oral bacterial DNAs. Clin Exp Rheumatol 2006; 24:656-663. (Pubitemid 46138797)
14. Moen K, Brun JG, Eribe ERK, et al. Oral bacterial DNAs in synovial fluids of arthritis patients. Microb Ecol Health Dis 2005; 17:2-8. (Pubitemid 40694902)
15. Reichert S, Haffner M, Keyßer G, et al. Detection of oral bacterial DNA in synovial fluid. J Clin Periodontol 2013; 40:591-598. doi: 10.1111/jcpe.12102.
16. Wolff B, Berger T, Frese C, et al. Oral status in patients with early rheumatoid arthritis: a prospective, case-control study. Rheumatology (Oxford) 2014; 53:526-531.
17. Quirke AM, Lugli EB, Wegner N, et al. Heightened immune response to autocitrullinated Porphyromonas gingivalis peptidylarginine deiminase: a potential mechanism for breaching immunologic tolerance in rheumatoid arthritis. Ann Rheum Dis 2014; 73:263-269. doi: 10.1136/annrheumdis-2012-202726.
18. Demoruelle MK, Weisman MH, Simonian PL, et al. Brief report: airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: early injury or initiating site of autoimmunity? Arthritis Rheum 2012; 64:1756-1761. doi: 10.1002/art.34344.
19. Demoruelle MK, Norris JM, Holers VM, et al. The lung microbiome differs in asymptomatic subjects at elevated risk of future rheumatoid arthritis com pared with healthy control subjects. Ann Am Thorac Soc 2014; 11 (Suppl. 1): S74.
20. Bernard N J. Rheumatoid arthritis: Prevotella copri associated with new-onset untreated RA. Nat Rev Rheumatol 2014; 10:2. doi: 10.1038/nrrheum.2013. 187.
21. Breban M. Genetics of spondyloarthritis. Best Pract Res Clin Rheumatol 2006; 20:593-599. (Pubitemid 43843065)
22. Tani Y, Tiwana H, Hukuda S, et al. Antibodies to Klebsiella, Proteus, and HLA-B27 peptides in Japanese patients with ankylosing spondylitis and rheumatoid arthritis. J Rheumatol 1997; 24:109-114. (Pubitemid 27059867)
23. Ebringer R. Acute anterior uveitis and faecal carriage of Gram negative bacteria. Br J Rheumatol 1988; 27 (Suppl. 2):42-45.
24. Stone MA, Payne U, Schentag C, et al. Comparative immune responses to candidate arthritogenic bacteria do not confirm a dominant role for Klebsiella pneumonia in the pathogenesis of familial ankylosing spondylitis. Rheumatology (Oxford) 2004; 43:148-155. (Pubitemid 38219667)
25. Penttinen MA, Holmberg CI, Sistonen L, et al. HLA-B27 modulates nuclear factor kappaB activation in human monocytic cells exposed to lipopolysac-charide. Arthritis Rheum 2002; 46:2172-2180.
26. Rosenbaum JT, Davey MP. Time for a gut check: evidence for the hypothesis that HLA-B27 predisposes to ankylosing spondylitis by altering the micro-biome. Arthritis Rheum 2011; 63:3195-3198.
27. Taurog JD, Richardson JA, Croft JT, et al. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med 1994; 180:2359-2364. (Pubitemid 24351619)
28. Nickerson CL, Hanson J, David CS. Expression of HLA-B27 in transgenic mice is dependent on the mouse H-2D genes. J Exp Med 1990; 172:1255-1261. (Pubitemid 20343227)
29. Khare SD, Luthra HS, David CS. Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking beta 2-microglobulin: a model of human spon-dyloarthropathies. J Exp Med 1995; 182:1153-1158.
30. Sakaguchi S, Takahashi T, Hata H, et al. SKG mice, a new genetic model of rheumatoid arthritis. Arthritis Res Ther 2003; 5 (Suppl. 3):10.
31. Friswell M, Campbell B, Rhodes J. The role of bacteria in the pathogenesis of inflammatory bowel disease. Gut Liver 2010; 4:295-306.
32. Tannock GW. The bowel microbiota and inflammatory bowel diseases. Int J Inflamm 2010; 2010:954051.
33. Zhernakova A, Festen EM, Franke L, et al. Genetic analysis of innate immunity in Crohn's disease and ulcerative colitis identifies two susceptibility loci harboring CARD9 and IL18RAP. Am J Hum Genet 2008; 82:1202-1210.
34. Waterman M, Xu W, Stempak JM, et al. Distinct and overlapping genetic loci in Crohn's disease and ulcerative colitis: correlations with pathogenesis. Inflamm Bowel Dis 2011; 17:1936-1942.
35. Ciccia F, Alessandro R, Rizzo A, et al. Macrophage phenotype in the subclinical gut inflammation of patients with ankylosing spondylitis. Rheumatol ogy 2014; 53:104-113.
36. De Vos M, Mielants H, Cuvelier C, et al. Long-term evolution of gut inflammation in patients with spondyloarthropathy. Gastroenterology 1996; 110:1696-1703. (Pubitemid 26169205)
37. Van Praet L, Van den Bosch FE, Jacques P, et al. Microscopic gut inflammation in axial spondyloarthritis: a multiparametric predictive model. Ann Rheum Dis 2013; 72:414-417.
38. Wallis D, Asaduzzaman A, Weisman M, et al. Elevated serum antiflagellin antibodies implicate subclinical bowel inflammation in ankylosing spondylitis. Arthritis Res Ther 2013; 15:R166.
39. Van Praet L, Jans L, Carron P, et al. Degree of bone marrow oedema in sacroiliac joints of patients with axial spondyloarthritis is linked to gut inflammation and male sex: results from the GIANT cohort. Ann Rheum Dis 2014; 73:1186-1189. doi: 10.1136/annrheumdis-2013-203854.
40. Evaluation of health and nutritional properties of powder milk and live lactic acid bacteria. Food and Agriculture Organization of the United Nations and World Health Organization Expert Consultation Report; 1-4 October 2001; Cordova, Argentina.
41. Salazar N, Binetti A, Gueimonde M, et al. Safety and intestinal microbiota modulation by the exopolysaccharide-producing strains Bifidobacterium ani-malis IPLA R1 and Bifidobacterium longum IPLA E44 orally administered to Wistar rats. Int J Food Microbiol 2011; 144:342-351.
42. So JS, Kwon HK, Lee CG, et al. Lactobacillus casei suppresses experimental arthritis by downregulating T helper 1 effector functions. Mol Immunol 2008; 45:2690-2699.
43. Amdekar S, Singh V, Singh R, et al. Lactobacillus casei reduces the inflammatory joint damage associated with collagen-induced arthritis (CIA) by reducing the proinflammatory cytokines: Lactobacillus casei: COX-2 inhibitor. J Clin Immunol 2011; 31:147-154.
44. Dieleman LA, Goerres MS, Arends A, et al. Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment. Gut 2003; 52:370-376. (Pubitemid 36250056)
45. Vaghef-Mehrabany E, Alipour B, Homayouni-Rad A, et al. Probiotic supplementation improves inflammatory status in patients with rheumatoid arthritis. Nutrition 2014; 30:430-435. pii: S0899-9007(13)00439-5.
46. Sanges M, Valente G, Rea M, et al. Probiotics in spondyloarthropathy associated with ulcerative colitis: a pilot study. Eur Rev Med Pharmacol Sci 2009; 13:233-234.
47. Jenks K, Stebbings S, Burton J, et al. Probiotic therapy for the treatment of spondyloarthritis: a randomized controlled trial. J Rheumatol 2010; 37:2118-2125. doi: 10.3899/jrheum.100193.